Logo

Central Manchester University Hospitals to expand biomedical centre of excellence

Central Manchester University Hospitals Foundation Trust (CMFT) has announced a landmark £60m investment into its biomedical centre of excellence, alongside Manchester Science Partnership to expand on the trusts’ research and innovation facilities.
by David Ahluwalia
26 Jul 2016

Central Manchester University Hospitals Foundation Trust (CMFT) has announced a landmark £60m investment into its biomedical centre of excellence, alongside Manchester Science Partnership to expand on the trusts’ research and innovation facilities.

 

MSP’s investment will see CMFT’s campus add to its Citylabs biomedical centre of excellence with Citylabs 2.0 and 3.0; this move is estimated to bring in over £100m in economic growth and 750 new jobs to Manchester. Biomedical companies will be able to create innovative new health products at the site, with the NHS and patients able to reap the rewards of high-quality research and development in one of the UK’s leading cities.

 

CMFT’s partnership with MSP will see the delivery of clinical care, research and innovation – along with future developments on the CMFT estate. The trust’s Chair, Steve Mycio OBE, said the investment will mean “the NHS can ensure health technologies are developed that deliver better outcomes more efficiently to meet current and future needs of our patients and healthcare providers”.

 

CMFT’s full coverage of the story can be found here

Share this Article

← Shelford Group makes recommendations on future NHS funding and regulation → Delayed transfers of care reduced at Oxford University Hospitals NHS Foundation Trust by over 50%
© 2017 — The Shelford Group
Login

Keep up to date

Follow The Shelford Group on Twitter and our RSS Feed.

If you would like more information about the Shelford Group or to get in touch, please click here